Replies to post #2517 on Synaptogenix Inc (SNPX)

[runncoach]

Both, that's why this has the potential to be so big. It's in the presentations.

[F1ash]

"I thought NTRP was pitching regrowth of neurons, not "prevention of neuronal death".

"Pitching" that's what a company does when they run an unblinded, non-placebo controlled, undersized dose optimization study and then produce charts and graphs that span a period of several months that include over 20% dropouts labeled "all patients". "Pitching" occurs when said company says to retailer investors that those results actually "mean" something. (Just an example for illustrative purposes, any similarities to actual companies is purely coincidental).

NTRP never "pitched" neuronal regrowth. It was stimulation of synaptic regrowth and protection of neurons.

Slide A3


l. Synapse Regeneration
2. Prevention of Neuronal Death

3. Anti-Amyloid
4. Anti-tau

http://www.neurotropebioscience.com/Welcome_to_Neurotrope_BioScience/HomePage-Forms/neurotrope%20feb2017%20light.pdf